Contrary to conventional logic, which says that the interim government should not act populist, it has made an extremely harmful intervention in the pharmaceutical market. The regulation is “in the name of the people”, who will have to bear the secondary effects of it when it is repealed (as is expected) in a year.

Contrary to conventional logic, which says that the interim government should not act populist, it has made an extremely harmful intervention in the pharmaceutical market. The regulation is “in the name of the people”, who will have to bear the secondary effects of it when it is repealed (as is expected) in a year.